-
1دورية أكاديمية
المؤلفون: Blanc, E, Chaize, G, Fievez, S, Féger, C, Herquelot, E, Vainchtock, A, Timsit, J, F, Gaillat, J
المساهمون: Pfizer, VYOO Agency, EMIBiotech Paris (EMIB), AP-HP - Hôpital Bichat - Claude Bernard Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Centre Hospitalier Annecy-Genevois Saint-Julien-en-Genevois
المصدر: ISSN: 1471-2334 ; BMC Infectious Diseases ; https://inserm.hal.science/inserm-03356877Test ; BMC Infectious Diseases, 2021, 21 (1), pp.949. ⟨10.1186/s12879-021-06669-5⟩.
مصطلحات موضوعية: Community-acquired pneumonia, Pneumococcal pneumonia, At-risk comorbidities, High-risk comorbidities, Comorbidities stacking, Long-term mortality, Prognostic factors, Severe pneumonia, Elderly, Nonagenarians, [SDV]Life Sciences [q-bio]
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34521380; inserm-03356877; https://inserm.hal.science/inserm-03356877Test; https://inserm.hal.science/inserm-03356877/documentTest; https://inserm.hal.science/inserm-03356877/file/s12879-021-06669-5.pdfTest; PUBMED: 34521380; PUBMEDCENTRAL: PMC8442401
الإتاحة: https://doi.org/10.1186/s12879-021-06669-5Test
https://inserm.hal.science/inserm-03356877Test
https://inserm.hal.science/inserm-03356877/documentTest
https://inserm.hal.science/inserm-03356877/file/s12879-021-06669-5.pdfTest -
2دورية أكاديمية
المؤلفون: Blanc, E, Chaize, G, Fievez, S, Féger, C, Herquelot, E, Vainchtock, A, Timsit, J, F, Gaillat, J
المساهمون: Pfizer, VYOO Agency, EMIBiotech Paris (EMIB), AP-HP - Hôpital Bichat - Claude Bernard Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Centre Hospitalier Annecy-Genevois Saint-Julien-en-Genevois
المصدر: ISSN: 1471-2334 ; BMC Infectious Diseases ; https://inserm.hal.science/inserm-03356877Test ; BMC Infectious Diseases, 2021, 21 (1), pp.949. ⟨10.1186/s12879-021-06669-5⟩.
مصطلحات موضوعية: Community-acquired pneumonia, Pneumococcal pneumonia, At-risk comorbidities, High-risk comorbidities, Comorbidities stacking, Long-term mortality, Prognostic factors, Severe pneumonia, Elderly, Nonagenarians, [SDV]Life Sciences [q-bio]
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34521380; inserm-03356877; https://inserm.hal.science/inserm-03356877Test; https://inserm.hal.science/inserm-03356877/documentTest; https://inserm.hal.science/inserm-03356877/file/s12879-021-06669-5.pdfTest; PUBMED: 34521380; PUBMEDCENTRAL: PMC8442401
الإتاحة: https://doi.org/10.1186/s12879-021-06669-5Test
https://inserm.hal.science/inserm-03356877Test
https://inserm.hal.science/inserm-03356877/documentTest
https://inserm.hal.science/inserm-03356877/file/s12879-021-06669-5.pdfTest -
3دورية أكاديمية
المؤلفون: Blanc, E, Chaize, G, Fievez, S, Féger, C, Herquelot, E, Vainchtock, A, Timsit, J, F, Gaillat, J
المساهمون: Pfizer, VYOO Agency, EMIBiotech Paris (EMIB), AP-HP - Hôpital Bichat - Claude Bernard Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité)-Université Sorbonne Paris Nord, Centre Hospitalier Annecy-Genevois Saint-Julien-en-Genevois
المصدر: ISSN: 1471-2334 ; BMC Infectious Diseases ; https://inserm.hal.science/inserm-03356877Test ; BMC Infectious Diseases, 2021, 21 (1), pp.949. ⟨10.1186/s12879-021-06669-5⟩.
مصطلحات موضوعية: Community-acquired pneumonia, Pneumococcal pneumonia, At-risk comorbidities, High-risk comorbidities, Comorbidities stacking, Long-term mortality, Prognostic factors, Severe pneumonia, Elderly, Nonagenarians, [SDV]Life Sciences [q-bio]
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34521380; inserm-03356877; https://inserm.hal.science/inserm-03356877Test; https://inserm.hal.science/inserm-03356877/documentTest; https://inserm.hal.science/inserm-03356877/file/s12879-021-06669-5.pdfTest; PUBMED: 34521380; PUBMEDCENTRAL: PMC8442401
الإتاحة: https://doi.org/10.1186/s12879-021-06669-5Test
https://inserm.hal.science/inserm-03356877Test
https://inserm.hal.science/inserm-03356877/documentTest
https://inserm.hal.science/inserm-03356877/file/s12879-021-06669-5.pdfTest -
4دورية أكاديمية
المؤلفون: Blanc, E, Chaize, G, Fievez, S, Féger, C, Herquelot, E, Vainchtock, A, Timsit, J, Gaillat, J
المساهمون: Pfizer, HEVA Lyon, EMIBiotech Paris (EMIB), AP-HP - Hôpital Bichat - Claude Bernard Paris, Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP)-Université Sorbonne Paris Nord, Centre Hospitalier Annecy-Genevois Saint-Julien-en-Genevois
المصدر: ISSN: 1471-2334.
مصطلحات موضوعية: Community-acquired pneumonia, Pneumococcal pneumonia, At-risk comorbidities, High-risk comorbidities, Comorbidities stacking, Long-term mortality, Prognostic factors, Severe pneumonia, Elderly, Nonagenarians, [SDV]Life Sciences [q-bio]
العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34521380; inserm-03356877; https://www.hal.inserm.fr/inserm-03356877Test; https://www.hal.inserm.fr/inserm-03356877/documentTest; https://www.hal.inserm.fr/inserm-03356877/file/s12879-021-06669-5.pdfTest; PUBMED: 34521380; PUBMEDCENTRAL: PMC8442401
الإتاحة: https://doi.org/10.1186/s12879-021-06669-5Test
https://www.hal.inserm.fr/inserm-03356877Test
https://www.hal.inserm.fr/inserm-03356877/documentTest
https://www.hal.inserm.fr/inserm-03356877/file/s12879-021-06669-5.pdfTest